Point72 Asia Singapore Pte. Ltd. Sells 1,195 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Point72 Asia Singapore Pte. Ltd. cut its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 71.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 467 shares of the company’s stock after selling 1,195 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Addus HomeCare were worth $54,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Addus HomeCare by 1.5% in the first quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the period. Wellington Management Group LLP raised its position in shares of Addus HomeCare by 1.2% in the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after purchasing an additional 9,548 shares during the period. Point72 Asset Management L.P. increased its position in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares during the period. Dimensional Fund Advisors LP increased its position in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the period. Finally, Principal Financial Group Inc. increased its position in Addus HomeCare by 20.9% during the second quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock worth $49,979,000 after acquiring an additional 74,488 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Stock Down 0.2 %

Shares of Addus HomeCare stock opened at $126.31 on Friday. The company has a market capitalization of $2.29 billion, a price-to-earnings ratio of 31.34, a PEG ratio of 2.40 and a beta of 1.04. Addus HomeCare Co. has a 12-month low of $78.35 and a 12-month high of $136.12. The firm’s 50-day moving average price is $128.88 and its two-hundred day moving average price is $116.34.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same period last year, the company posted $0.94 EPS. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on ADUS. Macquarie began coverage on shares of Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. TD Cowen raised their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $128.29.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.